The weight loss pill had a strong U.S. launch this year, and Novo believes that will be replicated in other markets around ...

Losing muscle, as well as fat, is an unexpected downside of the popular drugs that isn’t broadly discussed or immediately ...

After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo Nordisk is ...

On May 12, 2026, Eli Lilly and Company (NYSE:LLY) announced late-phase trial results showing that Foundayo (orforglipron) and ...

Adults with moderate to severe psoriasis and overweight or obesity were more likely to achieve complete skin clearance plus ...

Here is what could happen to Eli Lilly shares next.

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.

Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the most impressive quarters in big pharma history, and the ...

Novo Nordisk delivered strong Q1 results, with sales and margins exceeding expectations. Read why I continue to rate NVO ...